Skip to main navigation Skip to search Skip to main content

Most patients with multiple sclerosis or a clinically isolated demyelinating syndrome should be treated at the time of diagnosis

  • E. M. Frohman
  • , E. Havrdova
  • , F. Lublin
  • , F. Barkhof
  • , A. Achiron
  • , M. K. Sharief
  • , O. Stuve
  • , M. K. Racke
  • , L. Steinman
  • , H. Weiner
  • , M. Olek
  • , R. Zivadinov
  • , J. Corboy
  • , C. Raine
  • , G. Cutter
  • , J. Richert
  • , M. Filippi
  • Departments of Neurology and Ophthalmology
  • University of Texas at Dallas
  • Charles University
  • Icahn School of Medicine at Mount Sinai
  • VU University
  • Sheba Medical Center at Tel Hashomer
  • Tel Aviv University
  • Guy's and St Thomas' NHS Foundation Trust
  • Stanford University
  • Harvard University
  • University of California at Irvine
  • University of Colorado Denver
  • Albert Einstein College of Medicine
  • University of Alabama
  • National Multiple Sclerosis Society
  • San Raffaele Scientific Institute

Research output: Contribution to journalReview articlepeer-review

83 Scopus citations
Original languageEnglish
Pages (from-to)614-619
Number of pages6
JournalArchives of Neurology
Volume63
Issue number4
DOIs
StatePublished - Apr 2006

Fingerprint

Dive into the research topics of 'Most patients with multiple sclerosis or a clinically isolated demyelinating syndrome should be treated at the time of diagnosis'. Together they form a unique fingerprint.

Cite this